[HTML][HTML] Tracking cardiac engraftment and distribution of implanted bone marrow cells: comparing intra-aortic, intravenous, and intramyocardial delivery
SH Li, TYY Lai, Z Sun, M Han, E Moriyama… - The Journal of thoracic …, 2009 - Elsevier
OBJECTIVES: Cell therapy improved cardiac function after a myocardial infarction in several
preclinical studies; however, the functional benefits were limited in the initial clinical trials …
preclinical studies; however, the functional benefits were limited in the initial clinical trials …
[引用][C] Tracking cardiac engraftment and distribution of implanted bone marrow cells: Comparing intra-aortic, intravenous, and intramyocardial delivery
SH LI, TYY LAI, RK LI, Z SUN, M HAN… - Journal of thoracic …, 2009 - pascal-francis.inist.fr
Tracking cardiac engraftment and distribution of implanted bone marrow cells: Comparing
intra-aortic, intravenous, and intramyocardial delivery CNRS Inist Pascal-Francis CNRS …
intra-aortic, intravenous, and intramyocardial delivery CNRS Inist Pascal-Francis CNRS …
[PDF][PDF] Tracking cardiac engraftment and distribution of implanted bone marrow cells: Comparing intra-aortic, intravenous, and intramyocardial delivery
SH Li, TYY Lai, Z Sun, M Han, E Moriyama… - J Thorac Cardiovasc …, 2009 - core.ac.uk
Objectives: Cell therapy improved cardiac function after a myocardial infarction in several
preclinical studies; however, the functional benefits were limited in the initial clinical trials …
preclinical studies; however, the functional benefits were limited in the initial clinical trials …
Tracking cardiac engraftment and distribution of implanted bone marrow cells: Comparing intra-aortic, intravenous, and intramyocardial delivery
SH Li, TYY Lai, Z Sun, M Han… - The Journal of …, 2009 - pubmed.ncbi.nlm.nih.gov
Objectives Cell therapy improved cardiac function after a myocardial infarction in several
preclinical studies; however, the functional benefits were limited in the initial clinical trials …
preclinical studies; however, the functional benefits were limited in the initial clinical trials …
[HTML][HTML] Tracking cardiac engraftment and distribution of implanted bone marrow cells: Comparing intra-aortic, intravenous, and intramyocardial delivery
SH Li, TYY Lai, Z Sun, M Han, E Moriyama… - The Journal of Thoracic …, 2009 - jtcvs.org
Objectives Cell therapy improved cardiac function after a myocardial infarction in several
preclinical studies; however, the functional benefits were limited in the initial clinical trials …
preclinical studies; however, the functional benefits were limited in the initial clinical trials …
Tracking cardiac engraftment and distribution of implanted bone marrow cells: Comparing intra-aortic, intravenous, and intramyocardial delivery
SH Li, TYY Lai, Z Sun, M Han… - … of Thoracic and …, 2009 - augusta.elsevierpure.com
Objectives: Cell therapy improved cardiac function after a myocardial infarction in several
preclinical studies; however, the functional benefits were limited in the initial clinical trials …
preclinical studies; however, the functional benefits were limited in the initial clinical trials …
Tracking cardiac engraftment and distribution of implanted bone marrow cells: Comparing intra-aortic, intravenous, and intramyocardial delivery
SH Li, TYY Lai, Z Sun, M Han, E Moriyama… - The Journal of Thoracic …, 2009 - infona.pl
Cell therapy improved cardiac function after a myocardial infarction in several preclinical
studies; however, the functional benefits were limited in the initial clinical trials, perhaps …
studies; however, the functional benefits were limited in the initial clinical trials, perhaps …
[PDF][PDF] Tracking cardiac engraftment and distribution of implanted bone marrow cells: Comparing intra-aortic, intravenous, and intramyocardial delivery
SH Li, TYY Lai, Z Sun, M Han, E Moriyama… - J Thorac Cardiovasc …, 2009 - renkelilab.com
Objectives: Cell therapy improved cardiac function after a myocardial infarction in several
preclinical studies; however, the functional benefits were limited in the initial clinical trials …
preclinical studies; however, the functional benefits were limited in the initial clinical trials …
Tracking cardiac engraftment and distribution of implanted bone marrow cells: Comparing intra-aortic, intravenous, and intramyocardial delivery.
SH Li, TY Lai, Z Sun, M Han, E Moriyama… - The Journal of …, 2009 - europepmc.org
Objectives Cell therapy improved cardiac function after a myocardial infarction in several
preclinical studies; however, the functional benefits were limited in the initial clinical trials …
preclinical studies; however, the functional benefits were limited in the initial clinical trials …